David Veesler

country of citizenship: France

David Veesler is a French biochemist and an assistant professor in the Department of Biochemistry at the University of Washington, where his group focuses on the study the structural biology of infectious diseases. His team recently helped determine the structure of the SARS-CoV-2 spike glycoprotein using Cryo-EM techniques, and it is currently trying to identify neutralizing antibodies for SARS-CoV-2 that could be used as a preventative treatment against COVID-19 or as a post-exposure therapy using X-ray crystallography. Veesler is Howard Hughes Medical Investigators. Source: Wikipedia (en)

Series

There is nothing here

Create a new serie

Works

There is nothing here

Create a new work

Articles 21

Date

Title

Authors

2022-02-03

ACE2 binding is an ancestral and evolvable trait of sarbecoviruses

Tyler N Starr, Alexandra Walls, Sergey V. Alkhovsky, David Veesler, Jesse D. Bloom
2021-07-01

SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern

Matthew McCallum, Jessica Marcandalli, Anna De Marco, Alexandra Walls, Julia di Iulio, M. Alejandra Tortorici, Katja Culap, Siro Bianchi, Elisabetta Cameroni, John E Bowen, Matteo S Pizzuto, Laura E Rosen, Amalio Telenti, Herbert W. Virgin, Luca Piccoli, Davide Corti, David Veesler
2021-04-19

Adjuvanting a subunit COVID-19 vaccine to induce protective immunity

Alexandra Walls, Stephanie Fischinger, Venkata Viswanadh Edara, Katharina Röltgen, Deleah Pettie, Kasi Russell-Lodrigue, Skye Macpherson, Nicholas J Maness, Chad J Roy, Alex Zhu, Rino Rappuoli, Jason S McLellan, Scott D Boyd, JoAnne Flynn, Galit Alter, Neil P. King, David Veesler, Bali Pulendran, Caroline Atyeo
2021-04-29

Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins

Ha V Dang, Brandyn R West, Chad E Mire, Larry Zeitlin, Thomas W Geisbert, Christopher C Broder, David Veesler
2020-05-18

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

M. Alejandra Tortorici, Siro Bianchi, Katja Culap, James Brett Case, Colin Havenar-Daughton, David Veesler, Davide Corti, Herbert W. Virgin, Alexandra Walls, Antonio Lanzavecchia
2020-04-09

Structural and functional analysis of a potent sarbecovirus neutralizing antibody

Dora Pinto, Martina Beltramello, Siro Bianchi, Stefano Jaconi, Katja Culap, Anna De Marco, Alessia Peter, Barbara Guarino, Roberto Spreafico, Elisabetta Cameroni, Colin Havenar-Daughton, Amalio Telenti, Herbert W. Virgin, Antonio Lanzavecchia, Katja Fink, David Veesler, Davide Corti, James Brett Case, M. Alejandra Tortorici, Alexandra Walls
2020-04-24

Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 Spike protein for neutralization assays

Adam S Dingens, Andrea N. Loes, Helen Y. Chu, M. Alejandra Tortorici, David Veesler, Alejandro B Balazs, Jesse D. Bloom
2020-06-17

Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding

Tyler N Starr, Allison J Greaney, Sarah K Hilton, Katharine Dusenbury, M. Alejandra Tortorici, Alexandra Walls, David Veesler, Jesse D. Bloom
2020-08-04

Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens

George Ueda, Aleksandar Antanasijevic, Matthew J Bick, Philip J M Brouwer, David Veesler, Barney S. Graham, Per Johan Klasse, Andrew B Ward, David Baker, Rogier W Sanders, John P. Moore, Yaroslav Tsybovsky, Rebecca A Gillespie, Neil P. King, Masaru Kanekiyo
2020-08-04

Structure-guided covalent stabilization of coronavirus spike glycoprotein trimers in the closed conformation

John E Bowen, David Veesler, Alexandra Walls
2020-08-12

Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2

Marion Pepper, Timothy P Sheahan, Neil P. King, Ralph S. Baric, Sarah R Leist, Kendra Gully, Lisa E. Gralinski, Alexandra Schäfer, Alexandra Walls, Kenneth H Dinnon Iii, Longping V Tse, Brooke Fiala, Samuel Wrenn, Laila Shehata, Chengbo Chen, Mary Jane Navarro, Deleah Pettie, Rashmi Ravichandran, Cassandra Ogohara, Anne L Palser, Sara Chalk, Elizabeth Kepl, Cameron M Chow, Claire Sydeman, Edgar A. Hodge, Brieann Brown, Jim Fuller, Miklos Guttman, Paul Kellam, David Veesler
2020-09-01

Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak

Adam S Dingens, Fatima Amanat, Deleah Pettie, David Veesler, Florian Krammer, Jesse D. Bloom, Janet Englund, Alexandra Walls, Kirsten Lacombe, Amanda Adler, Rachel Eguia, Caitlin R Wolf, Neil P. King
2020-09-09

De novo design of picomolar SARS-CoV-2 miniprotein inhibitors

Longxing Cao, Brian Coventry, James Brett Case, Lauren Miller, Lauren Carter, Alexandra Walls, Eva-Maria Strauch, Lance Stewart, Michael S. Diamond, David Veesler, David Baker
2020-09-24

Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

M. Alejandra Tortorici, Martina Beltramello, Ha V Dang, Laura E Rosen, Matthew McCallum, John E Bowen, Anna De Marco, Barbara Guarino, Siro Bianchi, Heather Tucker, Jiayi Zhou, Alessia Peter, Colin Havenar-Daughton, Jason A Wojcechowskyj, James Brett Case, Hannah Kaiser, Martin Montiel-Ruiz, Marcel Meury, Nadine Czudnochowski, Roberto Spreafico, Josh Dillen, Cindy Ng, Nicole Sprugasci, Katja Culap, Fabio Benigni, Rana Abdelnabi, Caroline S Foo, Michael A Schmid, Elisabetta Cameroni, Agostino Riva, Arianna Gabrieli, Massimo Galli, Matteo S Pizzuto, Johan Neyts, Michael S. Diamond, Herbert W. Virgin, Katja Fink, David Veesler
2020-10-31

Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2

Sarah R Leist, Kendra Gully, Lisa E. Gralinski, Ralph S. Baric, Alexandra Schäfer, Alexandra Walls, Timothy P Sheahan, Neil P. King, Kenneth H Dinnon Iii, Longping V Tse, Brooke Fiala, Samuel Wrenn, Laila Shehata, Chengbo Chen, Mary Jane Navarro, Deleah Pettie, Rashmi Ravichandran, Cassandra Ogohara, Anne L Palser, Sara Chalk, Elizabeth Kepl, Cameron M Chow, Claire Sydeman, Edgar A. Hodge, Brieann Brown, Jim Fuller, Miklos Guttman, Paul Kellam, David Veesler
2020-11-27

Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020

Emma B. Hodcroft, Sarah Nadeau, Katharine Dusenbury, Jesse D. Bloom, David Veesler, Timothy G. Vaughan, Iñaki Comas, Fernando González-Candelas, Tanja Stadler, Richard A. Neher, Ana Milagro Beamonte
2020-12-01

Designed proteins assemble antibodies into modular nanocages

Robby Divine, Ha V Dang, George Ueda, Jorge A Fallas, Ivan Vulovic, William Sheffler, Shally Saini, Yan Ting Zhao, Infencia Xavier Raj, Peter A Morawski, Madeleine F Jennewein, Leah J Homad, Yu-Hsin Wan, Marti R Tooley, Ali Etemadi, Mitchell L Fahning, James Lazarovits, Alex Roederer, Alexandra Walls, Lance Stewart, Mohammadali Mazloomi, Neil P. King, Daniel J Campbell, Andrew McGuire, Leonidas Stamatatos, Hannele Ruohola-Baker, Julie Mathieu, David Veesler, David Baker
2019-06-03

Structural basis for human coronavirus attachment to sialic acid receptors

M. Alejandra Tortorici, David Veesler, Berend Jan Bosch, Alexandra Walls
2019-09-30

An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections

Christopher C Broder, David Veesler, Thomas W Geisbert, Barry Rockx
2019-12-02

Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors

M. Alejandra Tortorici, David Veesler, Berend Jan Bosch, Alexandra Walls
2018-11-07

Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core

Andrew J Borst, Andrew McGuire, Frank DiMaio, David Veesler, Peter D. Kwong, M Gordon Joyce, Ivelin S. Georgiev, Matthew D Gray, Guillaume Stewart-Jones

Human - wd:Q90391251

Welcome to Inventaire

the library of your friends and communities

learn more